1. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer;Abrams;Molecular Cancer Therapeutics,2003
2. American Cancer Society (2019) Key Statistics for Gastrointestinal Stromal Tumors. Available: https://www.cancer.org/cancer/gastrointestinal-stromal-tumor/about/key-statistics.html (Accessed November 2, 2020).
3. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging;Amin;CA: a Cancer Journal for Clinicians,2017
4. Comparison of Pet, Ct, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors;Antoch;Journal of Nuclear Medicine,2004
5. Ayvakit FDA Package Insert (n.d.) Ayvakit FDA Package Insert. Available: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-avapritinib-gastrointestinal-stromal-tumor-rare-mutation (Accessed April 16, 2021).